IL2 and neoplasm: Inhibited cell proliferation, cell cycle arrestment at G0/G1 phase, promote apoptosis via caspase 3 activation. Increased IL-2, TNF-α, INF-γ. Enhanced cytotoxicity of NK and T cells. Inhibited tumor growth and prolonged rat survival [316].